Lacey David L. 4
4 · Nurix Therapeutics, Inc. · Filed May 6, 2022
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Director Stock Option (right to buy)
2022-05-05+17,500→ 17,500 totalExercise: $10.39Exp: 2032-05-04→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 5, 2023, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.